Tradestie Institutional Equity Comparison Engine

BHST vs HLF โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HLF Overall Edge

HLF Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Herbalife Ltd. (HLF) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus HLF at 5.1x Forward P/E and 9.8% operating margin (+6.0% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HLF sits in SURGE (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HLF
BHST N/M vs HLF 5.1x Fwd P/E
Growth & Margin Winner HLF
Op Margin -18.0% vs 9.8% ยท YoY +3.8% vs +6.0%
Momentum & Technical Winner HLF
1Y -79.4% vs +68.4% ยท 52W Pos 6% vs 58%
Options & Structure Winner HLF
UNCLASSIFIED (N/A IV) vs SURGE (4th %ile IV)
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
1M Return -22.62%
1Y Return -79.4%
Forward P/E N/M
Unified AI Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
HLF NYSE
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$15.53
-0.26% 1D
Market Cap $1.6B
1M Return +12.7%
1Y Return +68.44%
Forward P/E 5.1x
Unified AI Score
47.4 / 100 HOLD
Tech 31.0 Fund 46.0 Flow 60.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHST -79.4% HLF +68.44% Spread: +147.84 pp (HLF Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BHST Revenue HLF Revenue BHST Op. Margin HLF Op. Margin Margin Edge
FY2018 N/A $4.89B N/A 14.0% HLF
FY2019 N/A $4.88B N/A 11.6% HLF
FY2020 N/A $5.54B N/A 11.6% HLF
FY2021 N/A $5.80B N/A 12.7% HLF
FY2022 N/A $5.20B N/A 10.5% HLF
FY2023 $10M $5.06B -78.6% 7.0% HLF
FY2024 $30M $4.99B -27.7% 7.7% HLF
FY2025 $30M $5.04B -16.2% 9.5% HLF

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHST (1) vs HLF (9)
Institutional Metric BHST HLF Criterion Row Winner
Market Capitalization Scale $29.9M $1.6B Larger Scale HLF
Trailing P/E Ratio Valuation N/M 9.2x Lower Multiple HLF
Forward P/E Ratio Valuation N/M 5.1x Lower Multiple HLF
Revenue Growth (YoY) Growth +3.8% +6.0% Higher Growth HLF
Operating Margin (TTM) Profitability -18.0% 9.8% Higher Margin HLF
Net Profit Margin Profitability -31.2% 3.4% Higher Margin HLF
Return on Equity (ROE) Capital Efficiency -142.5% 0.0% Higher ROE HLF
52-Week Range Position Momentum 6% ($1โ€“$7) 58% ($9โ€“$20) Stronger Trend HLF
Beta / 30D Volatility Risk Regime 0.25ฮฒ ยท 86% Vol 1.02ฮฒ ยท 50% Vol Lower Realized Risk HLF
Unified Institutional Score Composite Signal 58.2 / 100 (HOLD) 47.4 / 100 (HOLD) Higher Composite BHST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHST vs HLF Buy Guide
BHST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HLF SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live HLF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHST nor HLF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.